Norco and Gingivitis - a phase IV clinical study of FDA data

Summary:

Gingivitis is reported as a side effect among people who take Norco (acetaminophen; hydrocodone bitartrate), especially for people who are female, 50-59 old, also take Dilaudid, and have Osteoporosis.

The phase IV clinical study analyzes which people have Gingivitis when taking Norco. It is created by eHealthMe based on reports of 71,619 people who have side effects when taking Norco from the FDA, and is updated regularly.

What is Norco?

Norco has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 74,063 Norco users. Check the latest studies of Norco.

What is Gingivitis?

Gingivitis (inflammation of gums) is found to be associated with 886 drugs and 803 conditions by eHealthMe. Check the latest studies of Gingivitis.

On Jul, 15, 2026

71,619 people reported to have side effects when taking Norco.
Among them, 36 people (0.05%) have Gingivitis.

Among these 36 people:

What is the gender of people who have Gingivitis when taking Norco? *

female: 77.14 %
male: 22.86 %

What is the age of people who have Gingivitis when taking Norco? *

What are other drugs people take besides Norco? *

What are other side effects people have besides Gingivitis? *

Stress And Anxiety: 24 people, 66.67%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 21 people, 58.33%
Injury: 21 people, 58.33%
Osteonecrosis Of Jaw (death of bone of jaw): 20 people, 55.56%
Drowsiness: 20 people, 55.56%
Kidney Stones: 18 people, 50.00%
Chest Pain: 18 people, 50.00%
Abdominal Pain: 17 people, 47.22%
Joint Pain: 17 people, 47.22%
Pain In Jaw: 15 people, 41.67%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 7 people, 19.44%
Multiple Myeloma (cancer of the plasma cells): 6 people, 16.67%
Insomnia (sleeplessness): 5 people, 13.89%
Immunodeficiency Common Variable: 4 people, 11.11%
Diabetes: 3 people, 8.33%
Skin Ulcer: 3 people, 8.33%
Stress And Anxiety: 2 people, 5.56%
Depression: 2 people, 5.56%
High Blood Pressure: 2 people, 5.56%
Metastases To Bone (cancer spreads to bone): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Norco and have Gingivitis?

- Check whether Gingivitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Norco:

Norco (74,063 reports)

Gingivitis treatments and more:

Gingivitis (9,610 reports)

How severe was Gingivitis and when was it recovered:

Gingivitis in Norco

Expand to all the drugs that have ingredients of acetaminophen; hydrocodone bitartrate:

Gingivitis and drugs with ingredients of acetaminophen; hydrocodone bitartrate (374 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Norco:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gingivitis:

Gingivitis (886 drugs)

Browse all the conditions that are associated with Gingivitis:

Gingivitis (803 conditions)

Related publications that referenced our studies

Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; hydrocodone bitartrate (the active ingredients of Norco) and Norco (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.